Φορτώνει......
Combination of pegylated interferon‐alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients
A combination of pegylated interferon‐alpha (peg‐IFN‐α) and nucleos(t)ides analogue (NA) therapy can effectively reduce hepatitis B surface antigen (HBsAg), especially in NA‐experienced chronic hepatitis B (CHB) patients. However, the immune mechanism of this therapy is unclear. Forty NA‐experienced...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Exp Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7488124/ https://ncbi.nlm.nih.gov/pubmed/32638357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13486 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|